BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28076701)

  • 1. Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.
    Hopkins RJ; Duan F; Chiles C; Greco EM; Gamble GD; Aberle D; Young RP
    Ann Am Thorac Soc; 2017 Mar; 14(3):392-402. PubMed ID: 28076701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
    Young RP; Duan F; Chiles C; Hopkins RJ; Gamble GD; Greco EM; Gatsonis C; Aberle D
    Am J Respir Crit Care Med; 2015 Nov; 192(9):1060-7. PubMed ID: 26199983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Function Abnormalities in Smokers with Ischemic Heart Disease.
    Franssen FM; Soriano JB; Roche N; Bloomfield PH; Brusselle G; Fabbri LM; García-Rio F; Kearney MT; Kwon N; Lundbäck B; Rabe KF; Raillard A; Muellerova H; Cockcroft JR
    Am J Respir Crit Care Med; 2016 Sep; 194(5):568-76. PubMed ID: 27442601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
    Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
    Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should we be screening for COPD? - looking through the lens of lung cancer screening.
    Young RP; Scott RJ
    Expert Rev Respir Med; 2023; 17(9):753-771. PubMed ID: 37728077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.
    Undrunas A; Kasprzyk P; Rajca A; Kuziemski K; Rzyman W; Zdrojewski T
    BMJ Open; 2022 Apr; 12(4):e055007. PubMed ID: 35410926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017.
    Menezes AM; Wehrmeister FC; Perez-Padilla R; Viana KP; Soares C; Müllerova H; Valdivia G; Jardim JR; Montes de Oca M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1491-1501. PubMed ID: 28553101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
    Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
    Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of Airflow Limitation Based on z-Score Underestimates Mortality in Patients with Chronic Obstructive Pulmonary Disease.
    Tejero E; Prats E; Casitas R; Galera R; Pardo P; Gavilán A; Martínez-Cerón E; Cubillos-Zapata C; Del Peso L; García-Río F
    Am J Respir Crit Care Med; 2017 Aug; 196(3):298-305. PubMed ID: 28306326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airflow limitation classified with the fixed ratio or the lower limit of normal and cause-specific mortality - A prospective study.
    Torén K; Andersson M; Olin AC; Blanc PD; Järvholm B
    Respir Med; 2018 Nov; 144():36-41. PubMed ID: 30366582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile and preliminary results of Iranian sub cohort chronic obstructive pulmonary disease (COPD) in Shahrekord PERSIAN cohort in southwest Iran.
    Kiani FZ; Ahmadi A; Babadi AS; Rouhi H
    BMC Pulm Med; 2021 Mar; 21(1):105. PubMed ID: 33765987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep Disturbance in Smokers with Preserved Pulmonary Function and with Chronic Obstructive Pulmonary Disease.
    Donovan LM; Rise PJ; Carson SS; Feemster LC; Griffith MF; Kapur VK; Krishnan JA; Lindenauer PK; Mularski RA; Naureckas ET; Palen BN; Parsons EC; Spece LJ; Vitiello MV; Au DH;
    Ann Am Thorac Soc; 2017 Dec; 14(12):1836-1843. PubMed ID: 28825846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
    Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA
    JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the prevalence of airflow limitation in a general Japanese population: two serial cross-sectional surveys from the Hisayama Study.
    Ogata H; Hirakawa Y; Matsumoto K; Hata J; Yoshida D; Fukuyama S; Inoue H; Kitazono T; Ninomiya T; Nakanishi Y
    BMJ Open; 2019 Mar; 9(3):e023673. PubMed ID: 30898804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between airflow limitation and recurrence of venous thromboembolism among cancer patients with pulmonary embolism.
    Shin SH; Kang D; Cho J; Chang H; Kim MS; Lee SY; Lee H; Kim H; Kim DK; Kim EK; Park HY
    Int J Chron Obstruct Pulmon Dis; 2018; 13():937-943. PubMed ID: 29593386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of airflow limitation on medical check-up in Japanese subjects.
    Omori H; Nonami Y; Mihara S; Marubayashi T; Morimoto Y; Aizawa H
    J UOEH; 2007 Sep; 29(3):209-19. PubMed ID: 17900001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.